Newsroom

Feb 5, 2025

Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization

Terumo Neuro, a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the company is showcasing its comprehensive and streamlined portfolio of stroke solutions at the International Stroke Conference (ISC), February 4-7, 2025, at the Los Angeles Convention Center, booth number 522.

Oct 29, 2024

Terumo Neuro and Tulane University School of Medicine’s Dr. Kendrick Johnson Release Educational Video Highlighting the Importance of Stroke Awareness and Equitable Healthcare in Honor of World Stroke Day 2024

In honor of World Stroke Day on October 29, 2024, Terumo Neuro has partnered with Tulane University School of Medicine and Dr. Kendrick Johnson, Assistant Professor of Neurosurgery at Tulane University School of Medicine, to release a compelling educational video focused on raising awareness about stroke education and the critical need for equitable healthcare access.

Sep 12, 2024

MicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.

Feb 7, 2025

Neuro News

Terumo Neuro promotes fully integrated, comprehensive stroke portfolio at ISC 2025

Terumo Neuro has announced that the company is showcasing its comprehensive and streamlined portfolio of stroke solutions at booth number 522 at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA).

Nov 15, 2024

Orange County Business Journal

Terumo Neuro Debuts New Name, Expanded HQ

Orange County Business Journal highlights transformation to Terumo Neuro and the expansion of Aliso Viejo headquarters. This milestone reflects their commitment to advancing neurovascular innovation and enhancing patient outcomes worldwide. Read the full article here!

Sep 12, 2024

Associated Press

MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Strategic Growth

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.